scholarly journals The locus coeruleus: In‐vivo characterization with advanced MRI methods and associations with memory in older adults at risk for Alzheimer’s disease

2020 ◽  
Vol 16 (S4) ◽  
Author(s):  
Seraphina K. Solders ◽  
Alexandra L. Clark ◽  
Alexandra J. Weigand ◽  
Scott F. Sorg ◽  
Vitaly Galinsky ◽  
...  
2021 ◽  
Vol 29 (4) ◽  
pp. S51
Author(s):  
Andrew Dissanayake ◽  
Cristopher R. Bowie ◽  
Meryl A. Butters ◽  
Alastair Flint ◽  
Damien Gallagher ◽  
...  

2021 ◽  
Author(s):  
Cherie Strikwerda-Brown ◽  
Hazal Ozlen ◽  
Alexa Pichet Binette ◽  
Marianne Chapleau ◽  
Natalie Marchant ◽  
...  

Mindfulness, defined as the ability to engage in non-judgmental awareness of the present moment, has been associated with an array of health benefits. Mindfulness may also represent a protective factor for Alzheimer's disease (AD). Here, we tested the potential protective effect of trait mindfulness on cognitive decline and AD pathology in older adults at risk of AD dementia. Measures of trait mindfulness, longitudinal cognitive assessments, and AB- and tau- positron emission tomography (PET) scans were collected in 261 nondemented older adults with a family history of AD dementia from the PREVENT-AD observational cohort study. Multivariate partial least squares analyses were used to examine relationships between combinations of different facets of trait mindfulness and (1) cognitive decline, (2) AB, and (3) tau. Higher levels of trait mindfulness, particularly mindful nonjudgment, were associated with less cognitive decline, AB, and tau. Trait mindfulness may represent a psychological protective factor for AD dementia.


2020 ◽  
Vol 16 (S2) ◽  
Author(s):  
Fedor Levin ◽  
Irina Jelistratova ◽  
Tobey J. Betthauser ◽  
Sterling C. Johnson ◽  
Stefan J. Teipel ◽  
...  

2017 ◽  
Vol 49 (5S) ◽  
pp. 824-825
Author(s):  
Ryan J. Dougherty ◽  
Elizabeth A. Boots ◽  
Karly A. Cody ◽  
Stephanie A. Schultz ◽  
Dorothy F. Edwards ◽  
...  

2019 ◽  
Vol 30 (4) ◽  
pp. 2083-2098
Author(s):  
Jose L Cantero ◽  
Mercedes Atienza ◽  
Carmen Lage ◽  
Laszlo Zaborszky ◽  
Eduard Vilaplana ◽  
...  

Abstract Evidence suggests that the basal forebrain (BF) cholinergic system degenerates early in the course of Alzheimer’s disease (AD), likely due to the vulnerability of BF cholinergic neurons to tau pathology. However, it remains unclear whether the presence of tauopathy is the only requirement for initiating the BF degeneration in asymptomatic subjects at risk for AD (AR-AD), and how BF structural deficits evolve from normal aging to preclinical and prodromal AD. Here, we provide human in vivo magnetic resonance imaging evidence supporting that abnormal cerebrospinal fluid levels of phosphorylated tau (T+) are selectively associated with bilateral volume loss of the nucleus basalis of Meynert (nbM, Ch4) in AR-AD individuals. Spreading of atrophy to medial septum and vertical limb of diagonal band Broca (Ch1–Ch2) occurred in both preclinical and prodromal AD. With the exception of A+, all groups revealed significant correlations between volume reduction of BF cholinergic compartments and atrophy of their innervated regions. Overall, these results support the central role played by tauopathy in instigating the nbM degeneration in AR-AD individuals and the necessary coexistence of both AD proteinopathies for spreading damage to larger BF territories, thus affecting the core of the BF cholinergic projection system.


2020 ◽  
Vol 89 ◽  
pp. 132-141 ◽  
Author(s):  
Vijay K. Venkatraman ◽  
Andrew Sanderson ◽  
Kay L. Cox ◽  
Kathryn A. Ellis ◽  
Christopher Steward ◽  
...  

2006 ◽  
Vol 14 (7S_Part_22) ◽  
pp. P1177-P1178
Author(s):  
Kelsey R. Thomas ◽  
Katherine J. Bangen ◽  
Alexandra J. Weigand ◽  
Joel S. Eppig ◽  
Madeleine L. Weharne ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document